EUVIMEDEUVIMED entdecken
Crossref

Amantadine Modulates Action‐Specific Neural Ensembles in Hypokinetic and Hyperkinetic Conditions

Gaurav Chattree iD, Radosław Chrapkiewicz, Yanping Zhang, Jane Li, Fatih Dinc, Mark J Schnitzer

Movement Disorders · 2026-10 · 41 (10) · 2723-2736

DOI: 10.1002/mds.70415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 22.07.2026. Verfasst von Gaurav Chattree und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Amantadine, Antiparkinson Agents, Hyperkinesis, Hypokinesia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: American Academy of Neurology, Chan Zuckerberg Biohub, American Parkinson Disease Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the classical model of basal ganglia circuitry, striatal spiny projection neurons of the direct and indirect pathways (dSPNs, iSPNs) promote and suppress movement, respectively, and exhibit unbalanced activity levels during hypokinetic or hyperkinetic conditions. Most therapies for these conditions are thought to work by rebalancing the relative activity of dSPNs and iSPNs toward normal levels. However, the mechanism of amantadine, which uniquely improves both hypokinetic and hyperkinetic conditions, is poorly understood.

Objective

Our aim was to determine whether amantadine restores motor function by normalizing the balance of dSPN and iSPN activity or through a distinct mechanism.

Methods

We used dual‐color two‐photon Ca 2+ imaging in the 6‐hydroxydopamine (6‐OHDA) mouse model of Parkinson's disease to concurrently monitor dSPN and iSPN dynamics across healthy, hypokinetic (parkinsonian), and hyperkinetic (dyskinetic) conditions.

Results

We evaluated both dSPN/iSPN activity balance and action‐specific neural ensemble activity in the dorsolateral striatum. In hypokinetic conditions, levodopa rescued the dSPN/iSPN imbalance but failed to restore the disrupted activity of the locomotion‐specific ensemble. Conversely, amantadine improved locomotion‐specific ensemble activity without normalizing the dSPN/iSPN imbalance. In hyperkinetic conditions, forelimb dyskinesias were characterized by neural activity patterns distinct from those encoding locomotion. Amantadine selectively suppressed the resting activity of forelimb dyskinesia ensembles without affecting locomotion‐coding ensembles or restoring pathway balance.

Conclusions

Levodopa and amantadine may act through distinct mechanisms, with levodopa normalizing pathway balance and amantadine modulating action‐specific neural ensembles. These findings support the importance of action‐coding disruptions during hypokinetic and hyperkinetic conditions and suggest that correcting them can restore motor function. © 2026 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmantadineAntiparkinson AgentsHyperkinesisHypokinesiaAnimalsMiceOxidopamineCorpus StriatumMedium Spiny NeuronsDisease Models, AnimalMaleNeuronsParkinson DiseaseMice, Inbred C57BL

Stichwörter der Autor:innen

AmantadineL‐DOPA‐induced dyskinesiaParkinson's diseasecalcium imagingneural ensemblesstriatumtwo‐photon

Substanzen

AmantadineAntiparkinson AgentsOxidopamine

Autor:innen und Institutionen

  • Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.
  • CNC Program, Stanford University, Stanford, California, USA.
  • James Clark Center, Stanford University, Stanford, California, USA.
  • Howard Hughes Medical Institute, Stanford University, Stanford, California, USA.
  • Department of Biology, Stanford University, Stanford, California, USA.
  • Department of Applied Physics, Stanford University, Stanford, California, USA.

ORCID-Profile: Gaurav Chattree

Förderung

  • American Academy of Neurology
  • Chan Zuckerberg Biohub
  • American Parkinson Disease Association
  • Ludwig Family Foundation
  • U.S. Department of Defense
  • Stanford Knight Initiative for Brain Resilience

Zitieren

APA

Chattree, G., Chrapkiewicz, R., Zhang, Y., Li, J., Dinc, F., & Schnitzer, M. J. (2026). Amantadine Modulates Action‐Specific Neural Ensembles in Hypokinetic and Hyperkinetic Conditions. Movement Disorders, 41(10), 2723-2736. https://doi.org/10.1002/mds.70415

Vancouver

Chattree G, Chrapkiewicz R, Zhang Y, Li J, Dinc F, Schnitzer MJ. Amantadine Modulates Action‐Specific Neural Ensembles in Hypokinetic and Hyperkinetic Conditions. Movement Disorders. 2026;41(10):2723-2736. doi:10.1002/mds.70415

BibTeX
@article{Chattree2026,
  author = {Chattree, Gaurav and Chrapkiewicz, Radosław and Zhang, Yanping and Li, Jane and Dinc, Fatih and Schnitzer, Mark J},
  title = {Amantadine Modulates Action‐Specific Neural Ensembles in Hypokinetic and Hyperkinetic Conditions},
  journal = {Movement Disorders},
  year = {2026},
  volume = {41},
  number = {10},
  pages = {2723--2736},
  doi = {10.1002/mds.70415}
}
Kostenlos starten →